Cloning, expression and purification of the influenza A (H9N2) virus M2e antigen and truncated Mycobacterium tuberculosis HSP70 as a fusion protein in Pichia pastoris

Protein Expression and Purification

Volumn 70, Issue 1, 2010, Pages 7-12

  Ebrahimi, Seyyed Mahmoud ^a   Tebianian, Majid ^a   Toghyani, Hadi ^a   Memarnejadian, Arash ^b   Attaran, Hamid Reza ^a  

^a RAZI VACCINE AND SERUM RESEARCH INSTITUTE   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

HSP70; Influenza A virus; M2e; Pichia pastoris; Vaccine

Indexed keywords

HEAT SHOCK PROTEIN 70; HYBRID PROTEIN; M2 PROTEIN, INFLUENZA A VIRUS; MATRIX PROTEIN; RECOMBINANT PROTEIN; VIRUS ANTIGEN;

ANIMAL; ARTICLE; GENETICS; IMMUNOLOGY; INFLUENZA VIRUS A H9N2; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR CLONING; MYCOBACTERIUM TUBERCULOSIS; PICHIA; RABBIT;

ANIMALS; ANTIGENS, VIRAL; CLONING, MOLECULAR; HSP70 HEAT-SHOCK PROTEINS; INFLUENZA A VIRUS, H9N2 SUBTYPE; MYCOBACTERIUM TUBERCULOSIS; PICHIA; RABBITS; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; VIRAL MATRIX PROTEINS;

INFLUENZA A VIRUS; INFLUENZAVIRUS A; MYCOBACTERIUM TUBERCULOSIS; ORTHOMYXOVIRIDAE; ORYCTOLAGUS CUNICULUS; PICHIA PASTORIS;

EID: 75549091330     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2009.11.001     Document Type: Article

References (27)

1. Gerhard W., Mozdzanowska K., and Zharikova D. Prospects for universal influenza virus vaccine. Emerg. Infect. Dis. 12 (2006) 569-574
2. Ebrahimi S.M., Aghaiypour K., and Nili H. Sequence analysis of M2 gene of avian influenza virus strain (A/chicken/Iran/101/98 (H9N2)) as an oil vaccine seed. Iran. J. Biotechnol. 6 (2008) 229-232
3. Zebedee S.L., and Lamb R.A. Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions. J. Virol. 62 (1988) 2762-2772
4. Treanor J.J., Tierney E.L., Zebedee S.L., Lamb R.A., and Murphy B.R. Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice. J. Virol. 64 (1990) 1375-1377
5. Slepushkin V.A., Katz J.M., Black R.A., Gamble W.C., Rota P.A., and Cox N.J. Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein. Vaccine 13 (1995) 1399-1402
6. Neirynck S., Deroo T., Saelens X., Vanlandschoot P., Jou W.M., and Fiers W. A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat. Med. 5 (1999) 1157-1163
7. Tompkins S.M., Zhao Z.S., Lo C.Y., Misplon J.A., Liu T., and Ye Z. Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1. Emerg. Infect. Dis. 13 (2007) 426-435
8. Ernst W.A., Kim H.J., Tumpey T.M., Jansen A.D., Tai W., and Cramer D.V. Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines. Vaccine 24 (2006) 5158-5168
9. Jegerlehner A., Schmitz N., Storni T., and Bachmann M.F. Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity. J. Immunol. 172 (2004) 5598-5605
10. Fan J., Liang X., Horton M.S., Perry H.C., Citron M.P., and Heidecker G.J. Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys. Vaccine 22 (2004) 2993-3003
11. Hung C.F., Cheng W.F., Chai C.Y., Hsu K.F., He L., and Ling M. Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen. J. Immunol. 166 (2001) 5733-5740
12. Cusi M.G., Terrosi C., Savellini G.G., Di Genova G., Zurbriggen R., and Correale P. Efficient delivery of DNA to dendritic cells mediated by influenza virosomes. Vaccine 22 (2004) 735-739
13. Calarota S.A., and Weiner D.B. Enhancement of human immunodeficiency virus type 1-DNA vaccine potency through incorporation of T-helper 1 molecular adjuvant. Immunol. Rev. 199 (2004) 84-99
14. Qazia K.R., Wikmanb M., Vasconcelos N.-M., Berzins K., Stahl S., and Fernández C. Enhancement of DNA vaccine potency by linkage of plasmodium falciparum malarial antigen gene fused with a fragment of HSP70 gene. Vaccine 23 (2005) 1114-1125
15. Chen C.H., Wang T.L., Hung C.F., Yang Y., Young R.A., and Pardoll D.M. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene. Cancer Res. 60 (2000) 1035-1042
16. Wang Y., Kelly C.G., Singh M., McGowan E.G., Carrara A.S., Bergmeier L.A., and Lehner T. Stimulation of Th1-polarizing cytokines, C-C chemokines, maturation of dendritic cells, and adjuvant function by the peptide binding fragment of heat shock protein 70. J. Immunol. 169 (2002) 2422-2429
17. Li X., Yang X., Li L., Liu H., and Liu J. A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine. Vaccine 24 (2006) 3321-3331
18. S.M. Ebrahimi, M. Tebianian, K. Aghaiypour, H. Nili, A. Mirjalili, Prokaryotic expression and characterization of avian influenza A virus M2 gene as a candidate for universal recombinant vaccine against influenza A subtypes; specially H5N1 and H9N2, Mol. Biol. Rep., (2009), in press, doi:10.1007/s11033-009-9851-5.
19. Invitrogen, A Manual of Methods for Expression of Recombinant Proteins in Pichia pastoris, Catalogue No. V195-20.
20. Laemmli U.K. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 277 (1970) 680-685
21. Belshe R.B., Smith M.H., Hall C.B., Betts R., and Hay A.J. Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection. J. Virol. 62 (1988) 1508-1512
22. Leneva I.A., Roberts N., Govorkova E.A., Goloubeva O.G., and Webster R.G. The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses. Antiviral Res. 48 (2000) 101-115
23. Black R.A., Rota P.A., Gorodkova N., Klenk H.D., and Kendal A.P. Antibody response to the M2 protein of influenza A virus expressed in insect cells. J. Gen. Virol. 74 (1993) 143-146
24. S.M. Ebrahimi, M. Tebianian, Heterologous expression, purification and characterization of the influenza A virus M2e gene fused to Mycobacterium tuberculosis HSP70359-610 in prokaryotic system as a fusion protein, Mol. Biol. Rep., (2009), in press, doi:10.1007/s11033-009-9846-2.
25. Hardy E., Martínez E., Diago D., Díaz R., González D., and Herrera L. Large-scale production of recombinant hepatitis B surface antigen from Pichia pastoris. J. Biotechnol. 77 (2000) 157-167
26. Lamb R.A., Lai C.J., and Choppin P.W. Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins. Proc. Natl. Acad. Sci. USA 78 (1981) 4170-4174
27. Zebedee S.L., Richardson C.D., and Lamb R.A. Characterization of the influenza virus M2 integral membrane protein and expression at the infected-cell surface from cloned cDNA. J. Virol. 56 (1985) 502-511